PD-L1-IN-5

PD-1/PD-L1

Immunology/Inflammation, Cell Cycle/Checkpoint, Apoptosis

PD-L1-IN-5 (X22) is an orally active PD-L1 inhibitor with an IC50 of 785.6 nM, demonstrating antitumor activity in vivo.

Ice Packs

-20°C